Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health 

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. 

                    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and                           ( print page 54349)                        the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.                 

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, NIDA Clinical Science Conference Grant (R13) Review.                     

*Date:*                         September 29, 2010.                     

*Time:*                         9 a.m. to 5 p.m.                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852. (Virtual Meeting)                     

*Contact Person:*                         Gerald L. McLaughlin, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Blvd., Bethesda, MD 20892-8401. 301-402-6626.                         *gm145a@nih.gov.*

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, NIDA B/Start Small Grant Review.                     

*Date:*                         October 20, 2010.                     

*Time:*                         9 a.m. to 5 p.m.                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852. (Virtual Meeting)                     

*Contact Person:*                         Gerald L. McLaughlin, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Blvd., Bethesda, MD 20892-8401. 301-402-6626.                         *gm145a@nih.gov.*

*Name of Committee:*                         National Institute on Drug Abuse Initial Review Group, Training and Career Development Subcommittee.                     

*Date:*                         November 3-5, 2010.                     

*Time:*                         9 a.m. to 5 p.m.                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         Ritz-Carlton Hotel, 1150 22nd Street, NW., Rockville, MD 20852, Washington, DC 20037.                     

*Contact Person:*                         Kristen V. Huntley, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401. 301-435-1433.                         *huntleyk@mail.nih.gov.*

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, NIDA I/Start Small Grant Review.                     

*Date:*                         November 10, 2010.                     

*Time:*                         9 a.m. to 5 p.m.                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852. (Virtual Meeting.)                     

*Contact Person:*                         Gerald L. McLaughlin, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Blvd., Bethesda, MD 20892-8401. 301-402-6626.                         *gm145a@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)

                        Dated:                        **                         August 31, 2010.                     

Jennifer Spaeth, 

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-22183 Filed 9-3-10; 8:45 am] 

BILLING CODE 4140-01-P